The technology
Clinical application, differentiation, evidence and current regulatory position.
For Manufacturers
Brazil can offer meaningful opportunities for medical technology companies, but a product that can enter the country is not necessarily a product that can build a sustainable market.
C&L begins with the opportunity itself.
Introduce your technologyClinical application, differentiation, evidence and current regulatory position.
Existing alternatives, likely users and buyers, adoption barriers, pricing context and commercial positioning.
ANVISA/regulatory requirements, local operating needs, import/distribution considerations, launch requirements and commercial development.
Roles, economics, manufacturer support, responsibilities and long-term alignment.
There is no single C&L model.
Depending on the opportunity, collaboration may involve market-entry planning, regulatory coordination, commercial development, local representation, import/distribution structure, launch support and continued market development.
Product and clinical education should be designed with appropriate manufacturer participation and expertise.
Manufacturers & partnerships
If your company is evaluating Brazil, tell us what you are building and what you are trying to achieve.
We will review the opportunity before determining whether a deeper conversation makes sense.